243 related articles for article (PubMed ID: 20147738)
1. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
Lee B; Fast AM; Zhu J; Cheng JX; Buhman KK
J Lipid Res; 2010 Jul; 51(7):1770-80. PubMed ID: 20147738
[TBL] [Abstract][Full Text] [Related]
2. Intestinal acyl-CoA:diacylglycerol acyltransferase 2 overexpression enhances postprandial triglyceridemic response and exacerbates high fat diet-induced hepatic triacylglycerol storage.
Uchida A; Slipchenko MN; Eustaquio T; Leary JF; Cheng JX; Buhman KK
Biochim Biophys Acta; 2013 Aug; 1831(8):1377-85. PubMed ID: 23643496
[TBL] [Abstract][Full Text] [Related]
3. Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat.
Hung YH; Carreiro AL; Buhman KK
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):600-614. PubMed ID: 28249764
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
[TBL] [Abstract][Full Text] [Related]
5. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.
Villanueva CJ; Monetti M; Shih M; Zhou P; Watkins SM; Bhanot S; Farese RV
Hepatology; 2009 Aug; 50(2):434-42. PubMed ID: 19472314
[TBL] [Abstract][Full Text] [Related]
6. DGAT1 deficiency disrupts lysosome function in enterocytes during dietary fat absorption.
Hung YH; Buhman KK
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):587-595. PubMed ID: 30342099
[TBL] [Abstract][Full Text] [Related]
7. Dietary Macronutrient Composition Determines the Contribution of DGAT1 to Alcoholic Steatosis.
Huang LS; Yuen JJ; Trites MJ; Saha A; Epps CT; Hu Y; Kerolle S; Lee SA; Jiang H; Goldberg IJ; Blaner WS; Clugston RD
Alcohol Clin Exp Res; 2018 Dec; 42(12):2298-2312. PubMed ID: 30192394
[TBL] [Abstract][Full Text] [Related]
8. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.
Buhman KK; Smith SJ; Stone SJ; Repa JJ; Wong JS; Knapp FF; Burri BJ; Hamilton RL; Abumrad NA; Farese RV
J Biol Chem; 2002 Jul; 277(28):25474-9. PubMed ID: 11959864
[TBL] [Abstract][Full Text] [Related]
9. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
10. Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.
Sachdev V; Leopold C; Bauer R; Patankar JV; Iqbal J; Obrowsky S; Boverhof R; Doktorova M; Scheicher B; Goeritzer M; Kolb D; Turnbull AV; Zimmer A; Hoefler G; Hussain MM; Groen AK; Kratky D
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1132-1141. PubMed ID: 27344248
[TBL] [Abstract][Full Text] [Related]
11. The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes.
Chitraju C; Walther TC; Farese RV
J Lipid Res; 2019 Jun; 60(6):1112-1120. PubMed ID: 30936184
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue.
Chen HC; Stone SJ; Zhou P; Buhman KK; Farese RV
Diabetes; 2002 Nov; 51(11):3189-95. PubMed ID: 12401709
[TBL] [Abstract][Full Text] [Related]
14. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
15. Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin.
Streeper RS; Koliwad SK; Villanueva CJ; Farese RV
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E388-94. PubMed ID: 16595853
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding.
Yu F; Wang Z; Zhang T; Chen X; Xu H; Wang F; Guo L; Chen M; Liu K; Wu B
Nat Commun; 2021 Sep; 12(1):5323. PubMed ID: 34493722
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
19. Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance.
Nelson DW; Gao Y; Yen MI; Yen CL
J Biol Chem; 2014 Jun; 289(25):17338-49. PubMed ID: 24784138
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
Chen HC; Farese RV
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
